{"count": 3, "results": [{"_id": "33619022", "pmid": 33619022, "title": "Beta-Blockers Use and Risk of Breast Cancer in Women with Hypertension.", "journal": "Cancer Epidemiol Biomarkers Prev", "authors": ["Zheng G", "Sundquist J", "Sundquist K", "Ji J"], "date": "2021-05-01T00:00:00Z", "doi": "10.1158/1055-9965.EPI-20-1599", "meta_date_publication": "2021 May", "meta_volume": "30", "meta_issue": "5", "meta_pages": "965-973", "score": 50248.496, "text_hl": "Modification of agents acting on the @GENE_REN @GENE_5972 @@@renin@@@-angiotensin system on @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@ risk was also observed for @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Zheng G, Sundquist J, Sundquist K, Ji J. Beta-Blockers Use and Risk of Breast Cancer in Women with Hypertension. Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):965-973. PMID: 33619022", "BibTeX": "@article{33619022, title={Beta-Blockers Use and Risk of Breast Cancer in Women with Hypertension.}, author={Zheng G and Sundquist J and Sundquist K and Ji J}, journal={Cancer Epidemiol Biomarkers Prev}, volume={30}, number={5}, pages={965-973}}"}}, {"_id": "26728433", "pmid": 26728433, "pmcid": "PMC4700497", "title": "Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells", "journal": "Sci Rep", "authors": ["Talarico G", "Orecchioni S", "Dallaglio K", "Reggiani F", "Mancuso P", "Calleri A", "Gregato G", "Labanca V", "Rossi T", "Noonan DM", "Albini A", "Bertolini F"], "date": "2016-01-05T00:00:00Z", "doi": "10.1038/srep18673", "meta_date_publication": "2016 Jan 5", "meta_volume": "6", "meta_issue": "", "meta_pages": "18673", "score": 50055.65, "text_hl": "@CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Aspirin@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ enhance @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ activity against @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@ by targeting both neoplastic and microenvironment cells", "citations": {"NLM": "Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, Gregato G, Labanca V, Rossi T, Noonan DM, Albini A, Bertolini F. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells Sci Rep. 2016 Jan 5;6():18673. PMID: 26728433", "BibTeX": "@article{26728433, title={Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells}, author={Talarico G and Orecchioni S and Dallaglio K and Reggiani F and Mancuso P and Calleri A and Gregato G and Labanca V and Rossi T and Noonan DM and Albini A and Bertolini F}, journal={Sci Rep}, volume={6}, pages={18673}}"}}, {"_id": "21632503", "pmid": 21632503, "title": "Beta blockers and breast cancer mortality: a population- based study.", "journal": "J Clin Oncol", "authors": ["Barron TI", "Connolly RM", "Sharp L", "Bennett K", "Visvanathan K"], "date": "2011-07-01T00:00:00Z", "doi": "10.1200/JCO.2010.33.5422", "meta_date_publication": "2011 Jul 1", "meta_volume": "29", "meta_issue": "19", "meta_pages": "2635-44", "score": 50052.67, "text_hl": "There was no difference in T4 or N2/N3/@DISEASE_Leukemia_Myeloid_Acute @DISEASE_MESH:D015470 @@@M1 tumor@@@ incidence or @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@-specific mortality between @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ users and matched nonusers. ", "citations": {"NLM": "Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol. 2011 Jul 1;29(19):2635-44. PMID: 21632503", "BibTeX": "@article{21632503, title={Beta blockers and breast cancer mortality: a population- based study.}, author={Barron TI and Connolly RM and Sharp L and Bennett K and Visvanathan K}, journal={J Clin Oncol}, volume={29}, number={19}, pages={2635-44}}"}}]}